BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 121223
Published online Dec 14, 2026. doi: 10.3748/wjg.121223
Figure 4
Figure 4 Model interpretation and application. A: Scatter plots showing the relationship of actual values of included predictors with SHapley Additive exPlanations (SHAP) values and a second predictor with the strongest correlation; B: Feature importance ranked by mean absolute SHAP values; C: SHAP beeswarm plots illustrating impact distributions of included predictors; D: Online EXtreme Gradient Boosting prediction tool accessible at https://precrc.shinyapps.io/precrc/. A predicted probability ≥ 50% and < 50% is coded as 1 and 0, respectively; E: Percentage of incident advanced adenoma in EXtreme Gradient Boosting predicted high-risk and low-risk groups (0 = low risk, 1 = high risk). CA19-9: Carbohydrate antigen 19-9; CYFRA21-1: Cytokeratin 19 fragment; DBP: Diastolic blood pressure; FIT: Fecal immunochemical test; SHAP: SHapley Additive exPlanations; STK1p: Serum thymidine kinase 1 protein; XGBOOST: EXtreme Gradient Boosting.


Write to the Help Desk